Business Paid
Synthaverse to sell Onko BCG to South America for almost PLN 169 mln
15:28
Polish biotech company Synthaverse has signed two significant agreements with Brazil's Blau Farmacéutica to register, supply, and distribute its Onko BCG 100 cancer treatment in South America, totaling nearly PLN 169 million. The agreements cover seven countries: Brazil, Argentina, Colombia, Peru, Ecuador, Chile, and Paraguay.
This article is for subscribers
Warsaw Business Journal subscribers get the full archive (12,248 articles going back to 1995) and the print edition.
SubscribeOr try Poland A.M. free for 7 days, the daily briefing, or see all plans and prices.
